Nascent Biotech Inc (CE) (NBIO)
USOTC
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current NBIO market cap is 34.44k. The company's latest EPS is USD -0.0121 and P/E is 0.00.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 750k | 1M | 0 | 0 |
| Operating Income | -3.45M | -1.4M | -457k | -2.14M | -2.23M |
| Net Income | -4M | -959k | -470k | -2.8M | -2.09M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3k | 751k | 105k | 255k | 552k |
| Total Liabilities | 2.88M | 1.22M | 776k | 1.55M | 809k |
| Total Equity | -2.88M | -473k | -671k | -1.3M | -257k |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -554k | -987k | 414k | -1.79M | -1.19M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 426k | 985k | -321k | 1.87M | 1.39M |
| Market Cap | 34.44k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 172.2M |
| Average Volume (1 week) | 385.39k |
| Average Volume (1 Month) | 135.73k |
| 52 Week Change | -99.83% |
| 52 Week High | 0.19 |
| 52 Week Low | 0.0002 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Nascent Biotech Inc (CE) |
| Address |
623 17th street vero beach, florida 32960 |
| Website | https://www.nascentbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
